You are here: Home » News-CM » Companies » News
Business Standard

Caplin Point Laboratories announces appointment of director of Caplin Steriles

Capital Market 

has appointed M Panjatcharam (who was previously the of R&D - Quality at Sun Pharmaceuticals Industries) as a of (Wholly Owned Subsidiary Company) and as of Quality, R&D and Operations for the Company's regulated markets injectable business, including US approved injectable plant and DSIR recognised R&D Units & CP 5, which is now

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, April 11 2019. 12:18 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU